You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you’ll unleash scientists, accelerate their research and help get cures to patients sooner.
We’ve developed machines to fully automate human cell production - the most manual process in Biotech. Cells are used to discover and develop new drugs, and now they're being used to treat cancer too. Mytos will impact cure development across the board.
We're live in multibillion dollar biotechs on both coasts of the US, and just raised $19m to expand into the market faster, and accelerate our development!
We’ve assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. You can learn more about your potential Mytos teammates here: Team
Mytos is backed by Y Combinator, the most successful startup program in the world which produced companies such as AirBnb, Dropbox, and Ginkgo Bioworks.
This is an opportunity to redefine how the future of the biotech lab works. As the founding member of the Design team, you will be responsible for all aspects of Design at Mytos: from research, to concepting, to testing, to pixel-perfect UI. You’ll also define the design systems used across the whole company.
Aside from occasional hardware interactions, the entire surface area of our product is in software - ranging from setting up experiments, managing cell batches in real-time, and analysing data.
We’re building a team that enjoys moving fast, strives for continuous improvement through learning from mistakes and is passionate about work that contributes to solving real world problems. Join us if you want a fast-paced environment, where you’re empowered to make decisions and do the best work of your career.

Mytos automates production of stem cell-derived therapies - enabling them to scale to millions of patients at low cost. Our custom iDEM robotics platform powers our automated CDMO.
Our announced partnerships include neurons for treating Parkinson's, bone for bone repair, corneal cells for blindness, and auditory neurons for hearing loss (and we have more to announce). Cells produced on our iDEM platform will be going into patients by 2027.
Mytos has raised over $24m from leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists.
We're hiring now - visit our website to see open positions